跳至主要内容
临床试验/CTRI/2019/11/021917
CTRI/2019/11/021917招募中2 期

Efficacy of individualized homeopathic medicines in treatment of psoriasis vulgaris: Double-blind, randomized, placebo-controlled clinical trial

ational Institute of Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients suffering from mild to moderate psoriasis (PASI score 20 or less) for 3 months or more
  • 2. Age between 18-65 years
  • 3. Both sexes
  • 4. Patient willing to take part in the study and giving written consent
  • 5. Literate patients; ability to read English and/or Bengali

排除标准

  • 1. Severe psoriasis (PASI score more than 20)
  • 2. Patient who are too sick for consultation
  • 3. Unable to read patient information sheets and not giving consent to take part
  • 4. Psoriasis with complications like erythroderma and pustules
  • 5. Diagnosed cases of unstable psychiatric illness or other systemic disease affecting quality of life
  • 6. Currently receiving homeopathic treatment for chronic condition(s)
  • 7. Pregnant and lactating women
  • 8. Self-reported immune-compromised state
  • 9. Substance abuse and/or dependence

研究者

发起方
ational Institute of Homoeopathy

相似试验